PD Dr. Markus Eckstein

Professur für Translationale Immunpathologie (Else Kröner Clinician Scientist Professur) Institute of Pathology

International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer: Working Group 2: The Urinary Bladder (2026) Downes MR, Wobker SE, Smith SC, Eckstein M, Akgul M, Baydar DE, Brimo F, et al. Journal article Assessment of EGFR and HER2 expression in penile cancer as potential therapeutic targets (2026) Mink JN, Boehle J, Eckstein M, Fiegl A, Khalmurzaev O, Pryalukhin A, Geppert CI, et al. Journal article Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancer (2026) Scherping AK, Tomasik B, Luzha J, Schostak M, Jandrig B, Fehr A, Hartmann A, et al. Journal article Diagnostic and predictive molecular pathology of urothelial carcinoma: Current status and outlook for the future Diagnostische und prädiktive Molekularpathologie des Urothelkarzinoms: Bestandsaufnahme und Ausblick in die Zukunft (2026) Rauch S, Lange F, Hartmann A, Eckstein M Journal article The role of the tumor microenvironment in penile carcinoma and emerging therapeutic concepts: A review (2026) Fiegl A, Mink J, Junker K, Hartmann A, Eckstein M Journal article, Review article Nectin-4 in bladder cancer: biology and predictive biomarker potential. (2026) Roessler N, Miszczyk M, Berger W, Englinger B, Eckstein M, Shariat SF Journal article, Review article From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma Von ungezielt zu Präzisionsonkologie: Prädiktive Biomarker und Target-Therapien beim fortgeschrittenen Urothelkarzinom (2026) Niegisch G, Zschäbitz S, Eckstein M, Klümper N Journal article, Review article Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications Therapieinduziertes neuroendokrines Prostatakarzinom (tNEPC) – Eine Herausforderung in der Uro-Onkologie: Diagnostik, klinische Relevanz und therapeutische Perspektiven (2026) von Amsberg G, Hartmann A, Eckstein M, Heidegger I Journal article, Review article Immunohistochemical stratification of bladder small cell carcinoma reveals two major phenotypes with distinct therapeutic biomarker profiles (2026) Tenace NP, Colecchia M, Hartmann A, Ponzoni M, Doglioni C, Rauch S, Moschini M, et al. Journal article Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy (2025) Rinderknecht E, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR, Trombetta C, et al. Journal article